Merge Healthcare
About Us Press Room Investor Relations Human Resources Contact Us
Press Room
 

Merge eFilm Releases Fusion Server™ 1.0.
Server Platform and software application modules provide all-in-one PACS, Web Distribution and Teleradiology; Software-only approach provides flexible, scalable and affordable workflow solution.

Milwaukee, WI, September 30, 2002

Milwaukee, WI, September 30, 2002 – Merge eFilm today announced the release of FUSION Server 1.0, an integrated approach to filmless medical image and information management, designed to optimize workflow among clinicians throughout the healthcare enterprise. FUSION Server integrates database, image storage, and workflow capabilities on a unified, scalable platform that supports a suite of application modules, including HIS/RIS integration, archiving, image streaming, and image web access. This integrated or "fused" design minimizes necessary hardware, and allows additional capabilities to be instantly and effortlessly integrated, balances functional loads among multiple servers, provides fail-over flexibility, and is easily scalable as study volume increases.

"FUSION Server has allowed us to confidently transition from a film-based workflow to a filmless environment," said Andrew Watt, MD, Chief of Radiology at Yorkhill Hospital, a leading children’s hospital in Glasgow, Scotland. "It has allowed us to build a solid foundation that benefits our organization today, with better referring physician access, patient management, and the elimination of film. In addition, it positions us to leverage this foundation for a fully electronic patient record."

"With Fusion Server, we were able to maximize our archive investment and expand access to images beyond the walls of Radiology," said George Simpson, Radiology Manager, Dr. Gray’s Hospital, Elgin, Scotland. "FUSION Server provided us with a single solution that is scalable, whether our need is simple teleradiology or full PACS functionality. It provides the speed, performance and clinical quality that is crucial for us to have productive, efficient and clinically optimal workflow."

"FUSION Server is the beginning of a new breed of software-based solutions that truly reflect the clinical, technical and referring relationship needs of our customers," said Richard Linden, President and CEO of Merge eFilm. "We have aggregated the functionality of several PACSbuilder products into a single, server-based application that delivers functionality to the customer based on their approach, in terms of timing and priority, to PACS, web distribution and teleradiology. Multi-server, multi-vendor configurations that require fork-lift hardware replacements to accommodate growth are a thing of the past with the FUSION Server platform. We will continue to design and develop clinically focused solutions that leverage new ways of thinking and innovative technological approaches, with particular emphasis on delivering an attractive value proposition to our customers."

Press Contact

Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214

Phone:
1-(414) 977-4254

Email Address: marketing@merge.com
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.